Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Natural Killer Cells From the Subcutaneous Adipose Tissue Underexpress the Nkp30 and Nkp44 in Obese Persons and Are Less Active Against Major Histocompatibility Complex Class I Non-Expressing Neoplastic Cells Publisher



Shoaehassani A1 ; Behfar M1 ; Mortazavitabatabaei SA1, 2 ; Ai J1 ; Mohseni R1 ; Hamidieh AA1, 3
Authors

Source: Frontiers in Immunology Published:2017


Abstract

There are many types of leukocytes reside in subcutaneous adipose tissue (SAT), and among them, natural killer cells (NKs) comprise a major part. We show that the NKs that reside in the SAT (adipose tissue-derived NK cells; ADNKs) of the abdominal region found with phenotypic differences from the NKs circulating in the peripheral blood derived NK cells (PBNKs). In this survey, flow cytometry phenotyping was used to study the differences between the natural cytotoxicity receptor expression on ADNKs and PBNKs of both obese and lean persons. Also, their cytotoxicity and cytokine production patterns were evaluated. The activation experiments on isolated and expanded NKs with IL-2, IL-15, and IL-21 cytokines revealed the main population of the CD56dim within the total ADNKs of obese persons has an under-expression of NKp30 and NKp44 despite the unchanged levels of NKG2D. The data suggest the suppressive condition of the adipose tissue niche on the NKs response against sensitive major histocompatibility complex class I non-expressing neoplastic cells. As the NKs are the first line of the body's defense vs tumor formation, this change may lead to the development of transformed cells into the tumors. © 2017 Shoae-Hassani, Behfar, Mortazavi-Tabatabaei, Ai, Mohseni and Hamidieh.
Other Related Docs
8. Metabolic Risk Factors of Ovarian Cancer: A Review, Jornal Brasileiro de Reproducao Assistida (2022)
12. The Role of Nk Cells in Rheumatoid Arthritis, Inflammation Research (2021)
18. Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis, Current Stem Cell Research and Therapy (2016)